Increased NO-synthase activity and beneficial effect of PDE-5 inhibition by sildenafil in pulmonary hypertension caused by pulmonary embolism

被引：0
|
作者：
Mizera, Roman [1 ,2 ]
Hodyc, Daniel [1 ]
Herget, Jan [1 ]
机构：
[1] 2nd Med Sch Prague, Prague 5, Czech Republic
[2] KNL, Traumatol Orthopad Ctr, Liberec 1, Czech Republic
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
LB646
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Short Term Effect of Selexipag in Comparison to Prostacyclin Analogues in Pulmonary Arterial Hypertension Patients Started on Double-Combination Therapy with ERA and PDE-5 Inhibitors
    Dardi, F.
    Palazzini, M.
    Zuffa, E.
    De Lorenzis, A.
    Guarino, D.
    Pasca, F.
    Magnani, I.
    Rotunno, M.
    Ballerini, A.
    Manes, A.
    Galie, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [42] Treatment of fixed pulmonary arterial hypertension secondary to left ventricular dysfunction with PDE5 inhibition
    Hermes, AR
    Conte, JV
    Yuh, D
    Wittstein, IS
    Russell, S
    Hassoun, P
    Girgis, R
    Champion, HC
    CIRCULATION, 2005, 112 (17) : U152 - U152
  • [43] PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation
    Hemnes, Anna R.
    Zaiman, Ari
    Champion, Hunter C.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 294 (01) : L24 - L33
  • [44] SHORT-TERM EFFECT OF SELEXIPAG IN COMPARISON TO PROSTACYCLIN ANALOGUES IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION STARTED ON DOUBLE-COMBINATION THERAPY WITH ERA AND PDE-5 INHIBITORS
    Dardi, F.
    Manes, A.
    Ballerini, A.
    Guarino, D.
    Rotunno, M.
    De Lorenzis, A.
    Magnani, I.
    Donato, F.
    Bertozzi, R.
    Palazzini, M.
    Galie, N.
    CHEST, 2022, 161 (06) : 437A - 437A
  • [45] Short term effect of Selexipag in comparison to parenteral prostacyclin analogues in pulmonary arterial hypertension patients started on double-combination therapy with ERA and PDE-5 inhibitors
    Dardi, F.
    Zuffa, E.
    Palazzini, M.
    Pasca, F.
    De Lorenzis, A.
    Guarino, D.
    Magnani, I
    Ballerini, A.
    Rotunno, M.
    Manes, A.
    Galie, N.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2257 - 2257
  • [46] Effect of the PDE5-inhibitor sildenafil on calcium signalling and pulmonary vascular tone from chronically hypoxic rats
    Savineau, J. P.
    Pauvert, O.
    Bonnet, S.
    Rousseau, E.
    Marthan, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 77 - 77
  • [47] Rationale and study design of the RESPITE trial: Riociguat clinical effects studied in pulmonary arterial hypertension (PAH) patients with insufficient treatment response to PDE-5 inhibitors (PDE-5i)
    Hoeper, Marius
    Benza, Raymond
    Simonneau, Gerald
    Klinger, James
    Langleben, David
    Naeije, Robert
    Corris, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [48] Rationale and Study Design of the RESPITE Trial: Riociguat Clinical Effects Studied in Pulmonary Arterial Hypertension (PAH) Patients With Insufficient Treatment Response to PDE-5 Inhibitors (PDE-5i)
    Hoeper, Marius
    Benza, Raymond
    Klinger, James
    Simonneau, Gerald
    Langleben, David
    Naeije, Robert
    Corris, Paul
    CHEST, 2015, 148 (04)
  • [49] PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension
    Nassiba Merabet
    Mohamed Jalloul Nsaibia
    Quang Trinh Nguyen
    Yan Fen Shi
    Myriam Letourneau
    Alain Fournier
    Jean-Claude Tardif
    François Harel
    Jocelyn Dupuis
    Scientific Reports, 9
  • [50] PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension
    Merabet, Nassiba
    Nsaibia, Mohamed Jalloul
    Quang Trinh Nguyen
    Shi, Yan Fen
    Letourneau, Myriam
    Fournier, Alain
    Tardif, Jean-Claude
    Harel, Francois
    Dupuis, Jocelyn
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345